Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Patent

Addictive Learning Technology Patent

Addictive Learning Technology's word mark 'SKILL ARBITRAGE' has been registered with the Trademark Registry. This strengthens the company's brand protection and intellectual property rights.

Source

NSE filing, NSE: ADDICTIVE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Addictive Learning Technology Ltd: key numbers

Share price
₹40.50
Market cap
₹64.43 Cr
Revenue (annual)
₹75.72 Cr
Net profit (annual)
₹-0.48 Cr
P/E (TTM)
-133.5×Sector 34.1×
Promoter holding
63.96%+0.00% QoQ
FII holding
0.56%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Addictive Learning Technology Ltd

All →

Other patent announcements

All →
13:35 IST BSE
PatentAeroflex Industries Ltd AEROFLEX

Aeroflex Industries Patent

Aeroflex Industries secured an Indian patent for automated 3D CAD modeling of braided hose assemblies. The grant underscores its R&D and engineering innovation focus.

18:02 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.

08:58 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.

17:20 IST NSE
PatentUflex Ltd UFLEX

Uflex Patent

UFlex Limited received a patent from the Government of India for its 'High-Speed Twin Aseptic Pack Packaging Machine for Liquid Products'.

10:02 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.